The University of Chicago Header Logo
Last Name

Aritrick Chatterjee

TitleResearch Assistant Professor
InstitutionUniversity of Chicago
AddressChicago IL 60637
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California San Diego, USABS6/2010Bioengineering
    University College London, London, UKMSc9/2011Physics and Engineering in Medicine
    University of Sydney, Sydney, AustraliaPhD6/2016Health Science (MRI)
    University of Chicago, Chicago, IL, USAPostdoctoral Training1/2019Prostate MRI

    Collapse Research 
    Collapse research activities and funding
    RSNA Education Scholar Grant (ESCH1805)     (Aritrick Chatterjee)Jul 1, 2018 - Jun 30, 2020
    Radiological Society of North America (RSNA)
    An Interactive App with Multi-parametric MRI - Whole Mount Histology Correlation for Enhanced Prostate MRI Training of Radiologists
    Role: Principal Investigator

    1R01CA228036-01A1     (OTO, AYTEKIN)Apr 3, 2019 - Mar 31, 2024
    Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI
    Role: Co-Investigator

    Departmental Research Seed Funding     (Aritrick Chatterjee)Jul 1, 2019 - Jun 30, 2020
    Departmental of Radiology, University of Chicago
    MR based quantitative analysis and tissue composition measures in high risk population for prostate cancer: Racial discrepancies and impact on cancer detection
    Role: Principal Investigator

    CDAC Discovery Grant     (Aritrick Chatterjee)May 1, 2020 - Apr 30, 2021
    University of Chicago Center for Data and Computing (CDAC) (Chicago)
    Automated Prostate Cancer Detection using Hybrid Multi-dimensional MRI and Deep Learning
    Role Description: Apply deep learning methods to cutting-edge medical imaging to improve the diagnostic accuracy of detecting prostate cancer.
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Sun C, Wang S, Chatterjee A, Medved M, Eggener S, Karczmar GS, Oto A. T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy. Eur Radiol. 2020 Aug 12. PMID: 32785769.
      View in: PubMed
    2. Chatterjee A, Thomas S, Oto A. Prostate MR: pitfalls and benign lesions. Abdom Radiol (NY). 2020 07; 45(7):2154-2164. PMID: 31705249.
      View in: PubMed
    3. Chatterjee A, Harmath C, Oto A. New prostate MRI techniques and sequences. Abdom Radiol (NY). 2020 Apr 04. PMID: 32248259.
      View in: PubMed
    4. Chatterjee A, Nolan P, Sun C, Mathew M, Dwivedi D, Yousuf A, Antic T, Karczmar GS, Oto A. Effect of Echo Times on Prostate Cancer Detection on T2-Weighted Images. Acad Radiol. 2020 Jan 25. PMID: 31992480.
      View in: PubMed
    5. Chatterjee A, Sun C, Oto A. Reply to "Prostate Cancer Index Lesion Detection and Volume Estimation: Is Dynamic Contrast-Enhanced MRI Really Reliable?" AJR Am J Roentgenol. 2019 12; 213(6):W290. PMID: 31755764.
      View in: PubMed
    6. He D, Fan X, Chatterjee A, Wang S, Medved M, Pineda FD, Yousuf A, Antic T, Oto A, Karczmar GS. A compact solution for estimation of physiological parameters from ultrafast prostate dynamic contrast enhanced MRI. Phys Med Biol. 2019 08 07; 64(15):155012. PMID: 31220816.
      View in: PubMed
    7. Chatterjee A, Gallan AJ, He D, Fan X, Mustafi D, Yousuf A, Antic T, Karczmar GS, Oto A. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer. Abdom Radiol (NY). 2019 06; 44(6):2233-2243. PMID: 30955071.
      View in: PubMed
    8. Chatterjee A, He D, Fan X, Antic T, Jiang Y, Eggener S, Karczmar GS, Oto A. Diagnosis of Prostate Cancer by Use of MRI-Derived Quantitative Risk Maps: A Feasibility Study. AJR Am J Roentgenol. 2019 08; 213(2):W66-W75. PMID: 31039019.
      View in: PubMed
    9. Chatterjee A, Oto A. Future Perspectives in Multiparametric Prostate MR Imaging. Magn Reson Imaging Clin N Am. 2019 Feb; 27(1):117-130. PMID: 30466906.
      View in: PubMed
    10. Sun C, Chatterjee A, Yousuf A, Antic T, Eggener S, Karczmar GS, Oto A. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology. AJR Am J Roentgenol. 2019 02; 212(2):351-356. PMID: 30540213.
      View in: PubMed
    11. Knull E, Oto A, Eggener S, Tessier D, Guneyli S, Chatterjee A, Fenster A. Evaluation of tumor coverage after MR-guided prostate focal laser ablation therapy. Med Phys. 2019 Feb; 46(2):800-810. PMID: 30447155.
      View in: PubMed
    12. Chatterjee A, Tokdemir S, Gallan AJ, Yousuf A, Antic T, Karczmar GS, Oto A. Multiparametric MRI Features and Pathologic Outcome of Wedge-Shaped Lesions in the Peripheral Zone on T2-Weighted Images of the Prostate. AJR Am J Roentgenol. 2019 01; 212(1):124-129. PMID: 30403532.
      View in: PubMed
    13. He D, Chatterjee A, Fan X, Wang S, Eggener S, Yousuf A, Antic T, Oto A, Karczmar GS. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis. Invest Radiol. 2018 10; 53(10):609-615. PMID: 29702525.
      View in: PubMed
    14. Westin C, Chatterjee A, Ku E, Yousuf A, Wang S, Thomas S, Fan X, Eggener S, Karczmar G, Oto A. MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer. AJR Am J Roentgenol. 2018 09; 211(3):595-604. PMID: 29995499.
      View in: PubMed
    15. Chatterjee A, Devaraj A, Mathew M, Szasz T, Antic T, Karczmar GS, Oto A. Performance of T2 Maps in the Detection of Prostate Cancer. Acad Radiol. 2019 01; 26(1):15-21. PMID: 29731420.
      View in: PubMed
    16. Chatterjee A, Bourne RM, Wang S, Devaraj A, Gallan AJ, Antic T, Karczmar GS, Oto A. Diagnosis of Prostate Cancer with Noninvasive Estimation of Prostate Tissue Composition by Using Hybrid Multidimensional MR Imaging: A Feasibility Study. Radiology. 2018 06; 287(3):864-873. PMID: 29393821.
      View in: PubMed
    17. Chatterjee A, He D, Fan X, Wang S, Szasz T, Yousuf A, Pineda F, Antic T, Mathew M, Karczmar GS, Oto A. Performance of Ultrafast DCE-MRI for Diagnosis of Prostate Cancer. Acad Radiol. 2018 03; 25(3):349-358. PMID: 29167070.
      View in: PubMed
    18. Bourne RM, Bongers A, Chatterjee A, Sved P, Watson G. Diffusion anisotropy in fresh and fixed prostate tissue ex vivo. Magn Reson Med. 2016 08; 76(2):626-34. PMID: 26445008.
      View in: PubMed
    19. Chatterjee A, Watson G, Myint E, Sved P, McEntee M, Bourne R. Changes in Epithelium, Stroma, and Lumen Space Correlate More Strongly with Gleason Pattern and Are Stronger Predictors of Prostate ADC Changes than Cellularity Metrics. Radiology. 2015 Dec; 277(3):751-62. PMID: 26110669.
      View in: PubMed
    20. Siow B, Drobnjak I, Chatterjee A, Lythgoe MF, Alexander DC. Estimation of pore size in a microstructure phantom using the optimised gradient waveform diffusion weighted NMR sequence. J Magn Reson. 2012 Jan; 214(1):51-60. PMID: 22116034.
      View in: PubMed
    Chatterjee's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description